Jeffrey Tyner, Ph.D.

Head Shot of Jeffrey Tyner
click here

Selected Publications

"Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia," Clinical Cancer Research (Vol: 20, Issue: 8, Page 2092-2103) - 2014

"Functional integration of acute myeloid leukemia into the vascular niche," Leukemia - 2014

"Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization," Journal of Biological Chemistry (Vol: 289, Issue: 9, Page 5820-5827) - 2014

"PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma," Proceedings of the National Academy of Sciences of the United States of America (Vol: 111, Issue: 17, Page 6383-6388) - 2014

"Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations," Blood (Vol: 123, Issue: 10, Page 1516-1524) - 2014



  Email Jeffrey Tyner

503 346-0603